Syneos Health Inc (SYNH) Shares Sold by California Public Employees Retirement System – PressOracle
California Public Employees Retirement System trimmed its position in shares of Syneos Health Inc (NASDAQ:SYNH) by 12.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 109,039 shares of the company’s stock after selling 16,059 shares during the quarter. California Public Employees Retirement System owned approximately 0.11% of Syneos Health worth $4,291,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the business. Enlightenment Research LLC bought a new stake in shares of Syneos Health during the 4th quarter valued at $51,000. Oppenheimer Asset Management Inc. bought a new stake in shares of Syneos Health during the 4th quarter valued at $66,000. Private Capital Group LLC grew its position in shares of Syneos Health by 79.7% during the 4th quarter. Private Capital Group LLC now owns 1,824 shares of the company’s stock valued at $72,000 after acquiring an additional 809 shares during the period. Bank of Montreal Can grew its position in shares of Syneos Health by 70.7% during the 4th quarter. Bank of Montreal Can now owns 2,539 shares of the company’s stock valued at $99,000 after acquiring an additional 1,052 shares during the period. Finally, PNC Financial Services Group Inc. grew its position in shares of Syneos Health by 6.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 3,554 shares of the company’s stock valued at $141,000 after acquiring an additional 214 shares during the period.
Shares of NASDAQ SYNH opened at $50.35 on Friday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.97 and a current ratio of 0.99. The stock has a market cap of $5.22 billion, a PE ratio of 19.22, a price-to-earnings-growth ratio of 1.41 and a beta of 1.41. Syneos Health Inc has a 12-month low of $34.40 and a 12-month high of $56.34.
Syneos Health (NASDAQ:SYNH) last announced its earnings results on Monday, March 18th. The company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.16. The firm had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.15 billion. Syneos Health had a net margin of 0.55% and a return on equity of 9.60%. The business’s revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.70 EPS. As a group, sell-side analysts expect that Syneos Health Inc will post 2.72 EPS for the current year.
In related news, CEO Alistair Macdonald sold 6,697 shares of the stock in a transaction dated Tuesday, February 5th. The shares were sold at an average price of $53.04, for a total value of $355,208.88. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.57% of the stock is currently owned by corporate insiders.
Several brokerages recently weighed in on SYNH. Zacks Investment Research downgraded shares of Syneos Health from a “buy” rating to a “hold” rating in a report on Friday, November 30th. SunTrust Banks dropped their target price on shares of Syneos Health to $55.00 and set a “buy” rating for the company in a report on Wednesday, December 19th. Barclays dropped their target price on shares of Syneos Health from $51.00 to $45.00 and set an “equal weight” rating for the company in a report on Thursday, January 3rd. Finally, Robert W. Baird set a $60.00 target price on shares of Syneos Health and gave the stock a “buy” rating in a report on Tuesday, January 8th. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $52.70.
TRADEMARK VIOLATION WARNING: “Syneos Health Inc (SYNH) Shares Sold by California Public Employees Retirement System” was first posted by PressOracle and is the sole property of of PressOracle. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://pressoracle.com/news/2019/03/24/syneos-health-inc-synh-shares-sold-by-california-public-employees-retirement-system.html.
Syneos Health Profile
Syneos Health, Inc operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as unbundled service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process.
Recommended Story: Stop Order
Receive News & Ratings for Syneos Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Syneos Health and related companies with MarketBeat.com’s FREE daily email newsletter.